1.

Record Nr.

UNINA9910703055303321

Titolo

Measuring performance [[electronic resource] ] : developing good acquisition metrics : hearing before the Panel on Defense Acquisition Reform of the Committee on Armed Services, House of Representatives, One Hundred Eleventh Congress, first session, hearing held May 19, 2009

Pubbl/distr/stampa

Washington : , : U.S. G.P.O., , 2010

Descrizione fisica

1 online resource (iii, 84 pages) : illustrations

Soggetti

Defense contracts - United States - Evaluation

Government purchasing - United States - Evaluation

United States Armed Forces Procurement Evaluation

United States Armed Forces Appropriations and expenditures Evaluation

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Title from title screen (viewed on Nov. 10, 2010).

Paper version available for sale by the Supt. of Docs., U.S. G.P.O.

"H.A.S.C. no. 111-63."

Nota di bibliografia

Includes bibliographical references (pages 51-52).



2.

Record Nr.

UNINA9910300355403321

Autore

Yap Yee Guan

Titolo

Essentials of Atrial Fibrillation / / by Yee Guan Yap, A John Camm

Pubbl/distr/stampa

Tarporley : , : Springer Healthcare Ltd. : , : Imprint : Springer Healthcare, , 2014

ISBN

1-907673-98-9

Edizione

[1st ed. 2014.]

Descrizione fisica

1 online resource (54 p.)

Disciplina

610

613

614

615.1

Soggetti

Internal medicine

Public health

Cardiology

Hematology

Primary care (Medicine)

Pharmacotherapy

Internal Medicine

Public Health

Primary Care Medicine

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references at the end of each chapters.

Nota di contenuto

Epidemiology of atrial fibrillation -- Pathogenesis of atrial fibrillation -- Classification, diagnosis, and assessment of atrial fibrillation -- Rate and rhythm control strategies for atrial fibrillation -- Anticoagulant treatment strategies for atrial fibrillation.

Sommario/riassunto

This handbook offers timely investigation of current pharmaceutical trends, clinical guidelines, novel treatments, and ongoing pipeline developments, including ground-breaking advances in the use of novel oral anticoagulants. Atrial fibrillation (AF) affects an estimated 1–2% of the population and is the most common cause of sustained cardiac arrhythmia. Critically, the number of patients developing AF is expected to double in the next five decades, leading to increased incidence of



stroke, heart failure and other serious thromboembolic events.